190 related articles for article (PubMed ID: 34019202)
1. New insights into BMP9 signaling in liver diseases.
Jiang QQ; Liu BB; Xu KS
Mol Cell Biochem; 2021 Oct; 476(10):3591-3600. PubMed ID: 34019202
[TBL] [Abstract][Full Text] [Related]
2. New insights into BMP9 signaling in organ fibrosis.
Tang N; Rao S; Ying Y; Huang Y
Eur J Pharmacol; 2020 Sep; 882():173291. PubMed ID: 32574673
[TBL] [Abstract][Full Text] [Related]
3. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
4. Potential roles of BMP9 in liver fibrosis.
Bi J; Ge S
Int J Mol Sci; 2014 Nov; 15(11):20656-67. PubMed ID: 25393508
[TBL] [Abstract][Full Text] [Related]
5. Circulating Bone morphogenetic protein 9 (BMP9) as a new biomarker for noninvasive stratification of nonalcoholic fatty liver disease and metabolic syndrome.
Yang Y; Gu M; Wang W; Li S; Lu J; Sun Q; Hu M; Zhong L
Clin Exp Med; 2024 Mar; 24(1):55. PubMed ID: 38492130
[TBL] [Abstract][Full Text] [Related]
6. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.
Herrera B; García-Álvaro M; Cruz S; Walsh P; Fernández M; Roncero C; Fabregat I; Sánchez A; Inman GJ
PLoS One; 2013; 8(7):e69535. PubMed ID: 23936038
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.
Herrera B; Dooley S; Breitkopf-Heinlein K
Int J Mol Sci; 2014 Mar; 15(4):5199-220. PubMed ID: 24670474
[TBL] [Abstract][Full Text] [Related]
8. Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease.
Wood JH; Guo J; Morrell NW; Li W
Biochem Soc Trans; 2019 Jun; 47(3):779-791. PubMed ID: 31127068
[TBL] [Abstract][Full Text] [Related]
9. A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival.
Addante A; Roncero C; Lazcanoiturburu N; Méndez R; Almalé L; García-Álvaro M; Ten Dijke P; Fabregat I; Herrera B; Sánchez A
Cells; 2020 Mar; 9(3):. PubMed ID: 32204446
[TBL] [Abstract][Full Text] [Related]
10. BMP9 expression in the adult rat brain.
Ogawa C; Mikawa S; Hayashi Y; Masumoto K; Katou F; Sato K
J Chem Neuroanat; 2021 Apr; 113():101933. PubMed ID: 33582251
[TBL] [Abstract][Full Text] [Related]
11. BMP9 is a potential therapeutic agent for use in oral and maxillofacial bone tissue engineering.
Liu L; Chen Y; Song D; Huang D
Biochem Soc Trans; 2020 Jun; 48(3):1269-1285. PubMed ID: 32510140
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein (BMP)9 in cancer development: mechanistic, diagnostic, and therapeutic approaches?
Alkhathami AG; Abdullah MR; Ahmed M; Hassan Ahmed H; Alwash SW; Muhammed Mahdi Z; Alsaikhan F; Dera AA
J Drug Target; 2023 Aug; 31(7):714-724. PubMed ID: 37461888
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury.
Addante A; Roncero C; Almalé L; Lazcanoiturburu N; García-Álvaro M; Fernández M; Sanz J; Hammad S; Nwosu ZC; Lee SJ; Fabregat I; Dooley S; Ten Dijke P; Herrera B; Sánchez A
Liver Int; 2018 Sep; 38(9):1664-1675. PubMed ID: 29751359
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.
Song T; Wang W; Xu J; Zhao D; Dong Q; Li L; Yang X; Duan X; Liang Y; Xiao Y; Wang J; He J; Tang M; Wang J; Luo J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1639-46. PubMed ID: 23680673
[TBL] [Abstract][Full Text] [Related]
15. COX-2 promotes the osteogenic potential of BMP9 through TGF-β1/p38 signaling in mesenchymal stem cells.
Deng Y; Li L; Zhu JH; Li PP; Deng YX; Luo HH; Yang YY; He BC; Su Y
Aging (Albany NY); 2021 Apr; 13(8):11336-11351. PubMed ID: 33833129
[TBL] [Abstract][Full Text] [Related]
16. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
[TBL] [Abstract][Full Text] [Related]
17. Novel role of bone morphogenetic protein 9 in innate host responses to HCMV infection.
Stempel M; Maier O; Mhlekude B; Drakesmith H; Brinkmann MM
EMBO Rep; 2024 Mar; 25(3):1106-1129. PubMed ID: 38308064
[TBL] [Abstract][Full Text] [Related]
18. Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis.
Li P; Li Y; Zhu L; Yang Z; He J; Wang L; Shang Q; Pan H; Wang H; Ma X; Li B; Fan X; Ge S; Jia R; Zhang H
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):709-720. PubMed ID: 29223735
[TBL] [Abstract][Full Text] [Related]
19. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis.
Bai H; Lu Q; Wu C; Xu F; Liu J; Wang K; Ding H; Yin Y; Liu Y; Lai X; Cao J
Sci Transl Med; 2024 Jan; 16(732):eadi3275. PubMed ID: 38295185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
